Merit Medical Acquires Solo Pace, Inc., Expanding Its Cardiac Therapies Platform with Innovative TAVR Pacing Technology
Key Highlights
- ➤Merit Medical (MMSI) acquired Solo Pace for approximately $45 million on October 13, 2026.
- ➤Acquisition expands Merit’s Cardiac Therapies platform with SOLO PACE CONTROL and FUSION TAVR systems.
- ➤Acquisition is projected immaterial to Merit’s previously forecasted full-year 2026 results.
- ➤2027 acquisition impact: slightly accretive to non-GAAP earnings, slightly dilutive to GAAP earnings.
Expert Statements
David V. Daniels, MD, Interventional Cardiologist and Founder of Solo Pace
“SOLO PACE CONTROL and FUSION systems have the potential to redefine pacing in transcatheter valve procedures”
Martha G. Aronson, President and Chief Executive Officer of Merit Medical
“This acquisition expands our Cardiac Therapies platform and further strengthens our position in the structural heart market”
SOUTH JORDAN, Utah, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced its acquisition of Solo Pace, Inc. (Solo Pace). Located in Minneapolis, Minnesota, Solo Pace manufactures temporary pacing technology designed to help physicians treat patients with aortic stenosis. Merit had previously invested in Solo Pace and on October 13, 2026, Merit acquired all remaining outstanding equity of Solo Pace for purchase consideration of approximately $45 million.
The acquisition expands Merit’s Cardiac Therapies platform with differentiated technologies, including SOLO PACE CONTROL™ and SOLO PACE FUSION™ systems, exclusively engineered for transcatheter aortic valve replacement (TAVR) and other transcatheter heart valve (THV) procedures. Prior to the acquisition, Merit served as the exclusive distributor of Solo Pace’s precision intraprocedural pacing technology. The acquisition builds on this existing commercial relationship and supports Merit’s strategy to expand its structural heart portfolio, with a focus on technologies designed to simplify procedural workflows and support physicians performing transcatheter heart valve procedures.
Get started
Create a free account to read the full story.